Silsol could be on the money here.
PIQ partnered with Liner Clinical Research back in 2016 to analyze blood samples for patients in drug trials.
https://hotcopper.com.au/documentdownload?id=uOMxKKzFkiWRTLKhOROKAxjvTDYN6ge%2BwBKZsP5oke92GA%3D%3D
From the COVID19 update they do indicate building upon their existing network of partners.
Hope we are not connecting imaginary dots but the recent buying yesterday coupled with this news is all very interesting.
Have not heard from our resident Owl on the quarterly, she may having too much fun with DXB which is seeing a welcome rise.
GLTAH!
Ann: Appendix 4C and Quarterly Report - March 2020, page-18
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $49.87M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.5¢ | 28.5¢ | $201.7K | 642.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3253 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 57411 | 2 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |